Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any primary hypertrophic osteoarthropathy in which the cause of the disease is a mutation in the HPGD gene.
Features include: Limitation of joint mobility, Thickened calvaria, Seborrheic dermatitis, and Coarse facial features and 21 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 7 | Limitation of joint mobility, Weak and brittle bones (osteoporosis), Mild bone density loss (osteopenia) |
HPGD encodes 15-hydroxyprostaglandin dehydrogenase (266 aa). Catalyzes the NAD-dependent dehydrogenation (oxidation) of a broad array of hydroxylated polyunsaturated fatty acids (mainly eicosanoids and docosanoids, including prostaglandins, lipoxins and resolvins), yielding their corresponding keto (oxo) metabolites. Highest expression in Vagina (63.0 TPM) and Lung (51.5 TPM).
Hypertrophic osteoarthropathy, primary, autosomal recessive, 1 is associated with mutations in the HPGD gene on chromosome 4.
The HPGD protein participates in LXA4 is oxidised to 15k-LXA4 by HPGD, PGD2/E2/F2a is oxidised to 15k-PGD2/E2/F2a by HPGD, and PGH2 is isomerised to PGD2 by HPGDS pathways.
HPGD is classified as a druggable target (Druggable Genome, Enzyme, and Short Chain Dehydrogenase Reductase categories) with score 0.2.
Genetic testing for HPGD is available. Testing is considered confirmatory for diagnosis.
No clinical trials have been registered for hypertrophic osteoarthropathy, primary, autosomal recessive, 1.
14 publications have been identified in PubMed for hypertrophic osteoarthropathy, primary, autosomal recessive, 1. Research spans Case Report / Case Series (57%), Review / Meta-Analysis (14%), and Basic Science / Preclinical (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 8 | 57% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 5:32 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
6 |
Seborrheic dermatitis, Erythema, Excessive sweating (hyperhidrosis) |
Head and neck | 2 | Coarse facial features, High palate |
Muscles | 1 | Limitation of joint mobility |
Growth and development | 1 | Disproportionate tall stature |
Arms and legs | 1 | Osteolytic defects of the phalanges of the hand |
Eyes | 1 | Ptosis |
Research summaries |
2 |
14% |
Laboratory research | 2 | 14% |
Disease patterns and progression | 2 | 14% |
Magazin M (2026). [PMID: 41718423](https://pubmed.ncbi.nlm.nih.gov/41718423/). *Orbit*. [Review / Meta-Analysis]
Li J (2025). [PMID: 40140750](https://pubmed.ncbi.nlm.nih.gov/40140750/). *BMC Pediatr*. [Review / Meta-Analysis]
He Z (2025). [PMID: 40063344](https://pubmed.ncbi.nlm.nih.gov/40063344/). *QJM*. [Case Report / Case Series]
Arcanjo AM (2025). [PMID: 40144454](https://pubmed.ncbi.nlm.nih.gov/40144454/). *JBMR Plus*. [Epidemiology / Natural History]
Uludağ Alkaya D (2025). [PMID: 40198394](https://pubmed.ncbi.nlm.nih.gov/40198394/). *Calcif Tissue Int*. [Basic Science / Preclinical]
Patel DN (2025). [PMID: 40837897](https://pubmed.ncbi.nlm.nih.gov/40837897/). *Cureus*. [Case Report / Case Series]
Zehr K (2025). [PMID: 39840454](https://pubmed.ncbi.nlm.nih.gov/39840454/). *Am J Med Genet A*. [Case Report / Case Series]
Mohammad M (2025). [PMID: 41116940](https://pubmed.ncbi.nlm.nih.gov/41116940/). *Cureus*. [Case Report / Case Series]
Honaker E (2025). [PMID: 40390809](https://pubmed.ncbi.nlm.nih.gov/40390809/). *JBMR Plus*. [Case Report / Case Series]
Cai X (2025). [PMID: 40251683](https://pubmed.ncbi.nlm.nih.gov/40251683/). *Orphanet J Rare Dis*. [Case Report / Case Series]